MA H3574 | 2023-2024 | 193rd General Court

Note: Legislation replaced by H4739

Status

Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on March 30 2023 - 25% progression
Action: 2024-07-01 - Accompanied a study order, see H4739
Text: Latest bill text (Introduced) [PDF]

Summary

Relative to the use of a certain prescription medication used in psychotherapy and the treatment of post-traumatic stress disorder. Elder Affairs.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Concerning the use of a prescription medicine that contains 3,4-methylenedioxymethamphetamine (MDMA)

Sponsors


History

DateChamberAction
2024-07-01HouseAccompanied a study order, see H4739
2023-05-26JointHearing scheduled for 06/06/2023 from 01:00 PM-05:00 PM in Gardner Auditorium
2023-04-18SenateSenate concurred
2023-04-13HouseDischarged to the Joint Committee on Public Health
2023-03-30SenateSenate concurred
2023-03-30HouseReferred to the Joint Committee on Elder Affairs

Same As/Similar To

H4739 (Replaced by) 2024-07-01 - Discharged to the committee on House Rules

Massachusetts State Sources


Bill Comments

feedback